Cristina Oliva

Cristina Oliva serves as the Chief Medical Officer at Epsilogen Ltd since October 2025, following a tenure in the same position at BerGenBio ASA from April 2022 to October 2025. With extensive experience in oncology, Cristina held the role of Vice-President Oncology and Head of the Oncology Centre of Excellence at IQVIA from January 2019 to October 2021 and previously served as Senior Medical Director in Oncology at Quintiles from April 2016 to December 2019. Cristina's earlier positions include Chief Medical Officer at Nordic Nanovector ASA, Vice President Global Oncology R&D at Shionogi Limited, and Vice President Oncology at Takeda Global R&D. Additional roles encompass Executive Director Oncology Medicines Development at GlaxoSmithKline and Director of Medical Affairs Europe at Novuspharma SpA/ Cell Therapeutics S.r.l. Europe. Cristina holds a Doctor of Philosophy in Public Health from Kingston University, alongside a Board Certified degree in Oncology and a medical doctor degree in medicine and surgery from Università degli Studi di Genova.